Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

RESEPTOR 5-HT7 : Interest of the 5-HT7 Serotonin Receptor as a Biomarker in Multiple Sclerosis

NCT05746845 is registered in ClinicalTrials.gov with Centre Hospitalier Régional d'Orléans as lead sponsor.

NCT NCT05746845
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05746845 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
RESEPTOR 5-HT7 : Interest of the 5-HT7 Serotonin Receptor as a Biomarker in Multiple Sclerosis
Lead sponsor
Centre Hospitalier Régional d'Orléans
Phase
Observational
Overall status
Completed
Start date
March 6, 2023
Completion date
July 1, 2024
Enrollment
100 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

healthy, multiple sclerosis